Bio-Techne, Fresenius Kabi, and Wilson Wolf have formed a new joint venture company to provide dedicated support to researchers and biopharmaceutical companies in the field of cell and gene therapy. The joint venture will focus on providing scalable manufacturing technologies and processes needed to develop and commercialize new cell and gene therapies. Each of the […]
Cell line to be used to support research and development of biotherapeutics across therapeutic areas Cambridge, UK: Horizon Discovery Group plc (LSE: HZD) (“Horizon”, “the Company” or “the Group”), a global leader in the application of gene editing and gene modulation for cell line engineering, today announced that it will license its gene-edited Glutamine Synthetase […]
SAN DIEGO — COBO Technologies and Cardea Bio partner to bring solutions to challenges with the precision of Genome editing. The partners have agreed to co-develop and market a portfolio of CRISPR QC products and services for quality control (QC) of CRISPR research, agricultural, and pre-clinical programs. Over the longer-term, the parties aim to develop a […]
ANN ARBOR, Mich. — Genomenon® announced that over 175,000 recently documented genetic variants (DNA mutations) have been added to the Mastermind® Genomic Search Engine in the 4th quarter of 2019, for a cumulative total of more than 5.9 million genetic variants. This number reflects the rapidly accelerating pace of genomic discovery, and stands in stark contrast […]
VERSAILLES, France — ALGENTECH, announces the issuance of a key patent in the field of genome editing by the U.S. Patent Office (U.S. patent number 10457950). The technology claimed by the patent amplifies the effectiveness of gene editing in eukaryotic cells and can be applied in synergy with nucleases, including zinc finger nucleases, TALENs, Crispr-Cas9… Algentech’s […]
Under an instrument evaluation agreement, researchers at the University of Pennsylvania will explore utilization of “MARS” platform of Applied Cells to assist in protocol development for areas of advanced cancer diagnosis and cancer treatment. Santa Clara, California – University of Pennsylvania (Penn) and Applied Cells, Inc., a Santa Clara, California based biotechnology company, announced today […]
Genomic Vision (Paris:GV) (FR0011799907 – GV), a biotechnology company developing molecular assays and Artificial Intelligence tools to control quality and safety of genetically modified genomes, today announced that its Molecular Combing technology will be used by the US National Institute of Standards and Technology (NIST) to characterize and quantify intended and unintended genome editing events in […]
SAN CARLOS, Calif., Jan. 16, 2020 — CellFE, Inc., an innovative startup developing a microfluidics based device to deliver gene-editing molecules, today announced it has raised $3.6 million in an initial Series Seed. The oversubscribed round is co-led by Cota Capital and Dynamk Capital, and joined by Embark Ventures. The round is expected to close with additional investors […]
Munich, Germany – Perform high-resolution, cost-effective cell culture experiments with ibidi’s latest innovative labware technology, the µ-Slide 18 Well family. With its thin ibidi Polymer Coverslip Bottom, the µ-Slide 18 Well allows for excellent cell adhesion onto the tissue culture-treated surface. In addition, it has the highest optical quality and is ideally suited for a variety of […]
— Contract Focused on Making DNA Data Storage Commercially Accessible — SAN FRANCISCO– Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it has been selected as a subcontractor to Georgia Tech Research Institute (GTRI) to undertake the DNA […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
